Restricted Research - Award List, Note/Discussion Page

Fiscal Year: 2023

1802  The University of Texas at El Paso  (143690)

Principal Investigator: Schwartz,Ana Isabel

Total Amount of Contract, Award, or Gift (Annual before 2011): $ 605,440

Exceeds $250,000 (Is it flagged?): Yes

Start and End Dates: 4/13/23 - 3/31/27

Restricted Research: YES

Academic Discipline: Psychology

Department, Center, School, or Institute: Psychology

Title of Contract, Award, or Gift: SuRE: Bilingual discourse comprehension: How is text integration affected by overlap in language?

Name of Granting or Contracting Agency/Entity: NIH - NATL INST OF CHILD HEALTH & HU DEV

Program Title: #N/A

Note:

The specific aims of this proposal are to examine how the strength of cohort-activation (Specific Aim 1) and coherence-based retrieval (Specific Aim 2) are affected by the (1) match in language across texts, (2) genre of text and (3) cross-language reading experience for bilinguals. The overall approach to achieving these aims will consist of presenting Spanish-English bilingual university students pairs of text passages to read while their eye-movements are recorded. Half of the passages will be narratives and half will beexpository, science texts. Passages will contain some facts that are revised in the second passage, requiring the reader to update their representation of the discourse. Second passages will either be in the same or different language as the first passage. The impact of these variables on reading times for critical areas of text and responses to follow-up comprehension questions will be examined through linear mixed-effect models and ANCOVA’s. We will also include in the analyses scores that reflect participants’ experience reading in each of their languages. Findings from this research will inform educational practices that will enhance literacy and reading for linguistically-diverse students. This, in turn can enhance educational outcomes and serve as a pathway to better economical status that supports access to quality healthcare.

Discussion: No discussion notes

 

Close Window

Close Menu